Maria Lithoxopoulou | Health Professions | Best Researcher Award

Assist. Prof. Dr. Maria Lithoxopoulou | Health Professions | Best Researcher Award

Neonatologist -Pediatrics at Faculty of Medicine Aristotle University of Thessaloniki, Greece

Dr. Maria Lithoxopoulou is an esteemed Assistant Professor of Paediatrics-Neonatology at Aristotle University of Thessaloniki, Greece. With over 17 years of clinical experience as a Consultant Neonatologist, she has made significant contributions to neonatal care, focusing on neonatal infections, retinopathy of prematurity, and neonatal nutrition. She holds a Ph.D. in Neonatal Infections and an MBA in Health Administration, showcasing a blend of clinical, research, and administrative expertise. Her research is widely recognized, with 27 published articles, 79 citations, and a Scopus h-index of 5. She has collaborated with various national and international researchers to improve neonatal healthcare outcomes. Her contributions extend beyond neonatology to include ophthalmology, pediatric nutrition, and maternal health, demonstrating a broad and interdisciplinary research approach. Dr. Lithoxopoulou is fluent in Greek and English, with strong technical skills in Microsoft Office and data analysis. Her dedication to academia and research makes her a key figure in advancing neonatal healthcare practices. She is committed to improving neonatal treatment protocols, optimizing drug delivery for preterm infants, and reducing neonatal complications through evidence-based research. With a passion for both clinical and academic excellence, she continues to impact neonatology and pediatrics significantly.

Professional Profile

Education

Dr. Maria Lithoxopoulou has a strong academic background in medicine and healthcare management. She earned her Degree in Medicine from Aristotle University of Thessaloniki, Faculty of Medicine, Greece, in 1994, which laid the foundation for her career in pediatrics and neonatology. She later obtained a License to Practice in Paediatrics in 2003, allowing her to specialize in neonatal care. To further advance her expertise, she pursued a Ph.D. in Neonatal Infections, focusing on Signal Transducer and Activator of Transcription in Neonatal Infection, which she completed in 2012 at Aristotle University of Thessaloniki. In addition to her medical training, she obtained an MBA in Health Administration (2017), which equipped her with the necessary skills to manage and lead healthcare units effectively. She later acquired a Medical Specialty in Neonatology after passing rigorous exams. Her multifaceted education combines clinical, research, and administrative expertise, enabling her to contribute significantly to neonatal medicine, hospital management, and academic research. Dr. Lithoxopoulou’s commitment to education and continuous learning has allowed her to excel in both research and patient care, making her a leading figure in the field of pediatric neonatology.

Professional Experience

Dr. Maria Lithoxopoulou has a distinguished career in neonatology, with extensive experience in both clinical practice and academic research. She began her professional journey as a Consultant Neonatologist at General Hospital of G. Papageorgiou, Aristotle University of Thessaloniki, where she served from 2005 to 2022. During her tenure, she played a critical role in treating preterm and critically ill newborns, optimizing neonatal care protocols, and improving neonatal survival rates. In 2022, she transitioned into academia as an Assistant Professor in Paediatrics-Neonatology at Aristotle University of Thessaloniki, where she continues to mentor medical students, supervise research projects, and contribute to cutting-edge neonatal research. Throughout her career, she has collaborated with multidisciplinary teams in pediatric healthcare, focusing on neonatal infections, retinopathy of prematurity, neonatal nutrition, and early neonatal sepsis management. Her expertise extends to hospital administration, research project management, and neonatal pharmacology, allowing her to bridge the gap between clinical care and medical research. Dr. Lithoxopoulou’s contributions have enhanced neonatal treatment protocols, improved screening techniques for neonatal diseases, and shaped the next generation of neonatologists and pediatricians. Her dedication to both patient care and scientific advancement makes her a leading expert in her field.

Research Interests

Dr. Maria Lithoxopoulou’s primary research interests lie in the field of neonatology, with a strong focus on neonatal infections, neonatal ophthalmology, and neonatal nutrition. She has conducted extensive research on retinopathy of prematurity (ROP), exploring innovative screening techniques, drug delivery methods, and treatment outcomes. Her work also delves into neonatal sepsis, thrombocytopenia, and the effects of maternal health on neonatal outcomes, providing valuable insights into early disease detection and intervention strategies. In addition, she has a growing interest in neonatal pharmacology, particularly in optimizing drug delivery methods for preterm infants to improve treatment efficacy. Dr. Lithoxopoulou is also involved in research concerning pediatric nutrition and the prevention of neonatal malnutrition, emphasizing the role of maternal education in child growth and development. Her interdisciplinary approach has led her to collaborate with researchers in ophthalmology, public health, and biomedical sciences, broadening the impact of her work beyond neonatology. She is committed to advancing evidence-based practices in neonatal care by developing new clinical guidelines, conducting systematic reviews, and engaging in large-scale neonatal health studies. Her research significantly contributes to improving neonatal healthcare standards worldwide.

Research Skills

Dr. Maria Lithoxopoulou possesses advanced research skills in neonatology, clinical trials, and medical data analysis. She has expertise in study design, statistical analysis, and systematic reviews, allowing her to conduct high-quality, evidence-based research. She is proficient in using Scopus, ORCID, and Google Scholar for literature review and citation tracking. Her research skills include quantitative and qualitative data analysis, with experience in handling clinical datasets and patient records to draw meaningful conclusions. She has conducted randomized controlled trials, observational studies, and meta-analyses, particularly in neonatal ophthalmology, neonatal pharmacology, and neonatal infections. Additionally, she is skilled in scientific writing and publishing, with 27 published papers in peer-reviewed journals. She collaborates with multidisciplinary research teams, contributing to studies that impact neonatal healthcare on a global scale. Dr. Lithoxopoulou is also adept at grant writing and securing research funding, helping to advance her work in neonatology. With strong skills in Microsoft Office, PowerPoint presentations, and online research tools, she effectively communicates her findings at national and international conferences. Her expertise in data interpretation and clinical application makes her a valuable asset to neonatal research and academic medicine.

Awards and Honors

Dr. Maria Lithoxopoulou has received recognition for her contributions to neonatology and medical research. She has been acknowledged for her work in neonatal ophthalmology, particularly in improving screening techniques for retinopathy of prematurity (ROP). Her research on neonatal infections and thrombocytopenia has been cited as influential in shaping clinical guidelines for neonatal care. Additionally, she has participated in several national and international research projects, earning grants and funding for her innovative studies. Her dedication to neonatology has also been recognized through invitations to speak at international conferences, where she has presented her findings on neonatal pharmacology, neonatal nutrition, and early disease detection in preterm infants. She has contributed to high-impact medical journals and has played a key role in collaborative neonatal research initiatives. While her h-index (5) and citation count (79) are growing, her research continues to gain recognition in the scientific community. Her commitment to advancing neonatal healthcare through cutting-edge research, academic leadership, and clinical excellence makes her a strong candidate for prestigious research awards in pediatrics and neonatology.

Conclusion

Dr. Maria Lithoxopoulou is a highly accomplished neonatologist and researcher with a strong academic background, extensive clinical experience, and a significant research portfolio. Her work in neonatal infections, ophthalmology, and nutrition has led to valuable advancements in neonatal care and treatment protocols. With 27 research publications, a growing citation impact, and numerous contributions to neonatal medicine, she is a leading expert in her field. While she continues to expand her research influence, her commitment to academia, clinical excellence, and medical innovation makes her an outstanding candidate for the Best Researcher Award.

Publications Top Notes

  • Determination of macronutrient profile and energy composition in human milk via Mid‐Infrared Spectrometer Analysis: An experimental study

    • Authors: Maria Lithoxopoulou, Anastasia Gkampeta, Dimitrios Rallis, Katerina Tzafilkou, Eftychia Drogouti, Christos Tsakalidis
    • Year: 2025
  • A hydrophilic interaction liquid chromatography – Tandem mass spectrometry method for the determination of phenylephrine in dried blood spots from preterm infants

    • Authors: E. Boutou, C. Virgiliou, A.K. Seliniotaki, M. Lithoxopoulou, A. Mataftsi, N. Ziakas, E. Diamanti, N. Raikos, H. Gika
    • Year: 2022
  • Avoiding use of lid speculum and indentation reduced infantile stress during retinopathy of prematurity examinations

    • Authors: A. Mataftsi, M. Lithoxopoulou, A.K. Seliniotaki, P. Talimtzi, E. Oustoglou, E. Diamanti, V. Soubasi, N. Ziakas, A.-B. Haidich
    • Year: 2022
  • Population-Based Studies in Retinopathy of Prematurity and Screening Criteria Used

    • Authors: Stella Moutzouri, Aikaterini K. Seliniotaki, Maria Lithoxopoulou, Anna-Bettina Haidich, Nikolaos Ziakas, Asimina Mataftsi
    • Year: 2022
  • Clinical chorioamnionitis and histologic placental inflammation: association with early-neonatal sepsis

    • Authors: D. Rallis, M. Lithoxopoulou, S. Pervana, P. Karagianni, I. Hatziioannidis, V. Soubasi, C. Tsakalidis
    • Year: 2021
  • Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial

    • Authors: A.K. Seliniotaki, M. Lithoxopoulou, P. Talimtzi, E. Georgiou, E. Diamanti, N. Ziakas, A.-B. Haidich, A. Mataftsi
    • Year: 2021
  • Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis

    • Authors: I. Kopsidas, N.-M. Molocha, E. Kourkouni, S. Coffin, D. Gkentzi, E. Chorianopoulou, G. Dimitriou, A. Kapetanaki, G. Karavana, M. Lithoxopoulou, et al.
    • Year: 2021
  • Reducing duration of antibiotic use for presumed neonatal early-onset sepsis in Greek NICUs: A “low-hanging fruit” approach

    • Authors: I. Kopsidas, G.-C. Tsopela, N.-M. Molocha, E. Bouza, E. Chorafa, E. Chorianopoulou, V. Giapros, D. Gkentzi, T. Gkouvas, A. Kapetanaki, et al.
    • Year: 2021
  • A neonate with intrauterine growth restriction and pseudo-Bartter syndrome due to severe maternal eating disorder: A case report

    • Authors: E. Babatseva, I. Chatziioannidis, A.A. Tagaraki, D. Tramma, K. Dampala, E. Chatzitoliou, E. Papacharalambous, G. Mitsiakos, C. Tsakalidis, P. Karagianni, et al.
    • Year: 2020
  • Alternative mydriasis techniques for retinopathy of prematurity screening

    • Authors: A.K. Seliniotaki, E. Prousali, M. Lithoxopoulou, S. Kokkali, N. Ziakas, V. Soubasi, A. Mataftsi
    • Year: 2020

 

Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof. Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof Tehran university of medical sciences at Iran

Dr. Marjan Ghaemi is an accomplished gynecologist, obstetrician, and infertility specialist with a fellowship in endocrinology. She serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, Tehran University of Medical Sciences. With a strong background in both clinical and research fields, she has dedicated her career to advancing reproductive health. Her expertise spans infertility treatments, reproductive endocrinology, gynecological oncology, and minimally invasive surgery. Additionally, she has played a significant role in medical research and education, holding editorial positions in esteemed journals. Dr. Ghaemi has also contributed to digital health innovations, developing medical IT solutions and e-learning programs. With extensive experience in clinical research, trial management, and evidence-based medicine, she has been instrumental in improving reproductive healthcare. Her leadership in both academia and clinical practice has positioned her as a key figure in the field. Passionate about bridging the gap between research and patient care, she continues to explore new frontiers in reproductive medicine. Her contributions to gynecology and infertility research make her a strong contender for prestigious awards. She strives to integrate cutting-edge technology and medical advancements to enhance women’s healthcare, both nationally and internationally.

Professional Profile

Education

Dr. Marjan Ghaemi has an extensive educational background in medicine, gynecology, and reproductive endocrinology. She obtained her Doctorate in Medicine (MD) from Tehran University of Medical Sciences (TUMS), where she conducted research on the prevalence of polycystic ovary syndrome (PCOS) in adolescents. She further pursued specialization in obstetrics and gynecology at TUMS, achieving the highest national board exam score in OB/GYN in 2019. Her residency research focused on evaluating the quality of life in gynecological cancer patients using a web-based study. Dr. Ghaemi then completed a fellowship in infertility and endocrinology at TUMS, where she conducted a randomized controlled trial comparing different ovarian stimulation protocols in IVF patients with PCOS. Her educational achievements reflect her strong academic foundation and commitment to evidence-based medicine. With a focus on reproductive endocrinology, infertility treatments, and gynecological oncology, her research and clinical training have positioned her as a leader in her field. Her education not only provided her with deep clinical expertise but also honed her research skills, allowing her to contribute significantly to scientific advancements. Through her academic journey, she has consistently demonstrated excellence in both research and patient care, making significant contributions to reproductive medicine.

Professional Experience

Dr. Marjan Ghaemi has a distinguished professional career in clinical practice, academia, and research. She currently serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, TUMS, where she focuses on infertility treatments and reproductive endocrinology. She previously worked as an Assistant Professor at Kamali Hospital, Alborz University of Medical Sciences. Her expertise includes advanced infertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and minimally invasive gynecological surgeries. Dr. Ghaemi has also played a significant role in scientific publishing, serving as the Chief Editor of Fertility, Gynecology and Andrology and as an Associate Editor for the Journal of Family and Reproductive Health. Her research leadership extends to clinical trials and medical IT innovations. As a Clinical Research Manager at Farzan Clinical Research, she supervised multiple Phase II-IV studies and contributed to the development of digital health solutions, including e-learning platforms and medical applications. She has also worked extensively in hospital settings, managing complex cases in gynecology, obstetrics, and infertility. Her vast experience in research, patient care, and medical education makes her a well-rounded professional dedicated to advancing women’s health and reproductive medicine.

Research Interests

Dr. Marjan Ghaemi’s research focuses on reproductive endocrinology, infertility, and gynecological health. She has a particular interest in polycystic ovary syndrome (PCOS), exploring its prevalence, impact on fertility, and treatment options. Her work in in-vitro fertilization (IVF) has contributed to optimizing ovarian stimulation protocols, improving success rates for women with infertility. She is also interested in recurrent pregnancy loss and male infertility, expanding her research to encompass both partners in reproductive challenges. Additionally, Dr. Ghaemi has investigated the quality of life in gynecological cancer patients, seeking ways to enhance supportive care. Her research extends to hormonal therapies, reproductive surgeries, and minimally invasive techniques, contributing to advancements in assisted reproductive technology (ART). Another key area of her work involves the integration of digital health in reproductive medicine, including e-learning platforms and telemedicine for patient education. She is passionate about bridging the gap between clinical practice and research, ensuring that scientific advancements translate into better patient outcomes. Her multidisciplinary approach combines clinical expertise with innovative research methodologies, making her a leader in reproductive medicine. Through her studies, she aims to improve fertility treatments and reproductive health care, benefiting both patients and the scientific community.

Research Skills

Dr. Marjan Ghaemi possesses advanced research skills in clinical trials, reproductive endocrinology, and gynecological health. She is proficient in designing and conducting randomized controlled trials (RCTs), as demonstrated in her research on ovarian stimulation protocols in IVF. She has extensive experience in medical research methodologies, data analysis, and evidence-based practice. Her expertise in site monitoring, project management, and medical reporting has made her a key contributor to clinical research studies. Additionally, she has strong skills in digital health and medical IT, having developed e-learning platforms, mobile health applications, and smart e-health projects. Dr. Ghaemi’s editorial roles in leading medical journals have enhanced her abilities in scientific publishing, peer review, and manuscript editing. She is also skilled in medical writing and literature reviews, ensuring high-quality contributions to academic publications. Her experience in biostatistics and research ethics allows her to conduct rigorous and ethically sound studies. Furthermore, she has expertise in advanced imaging techniques such as gynecological and infertility ultrasound, enhancing her research capabilities in diagnostic medicine. Her diverse skill set in clinical and digital research makes her a valuable figure in reproductive medicine, contributing to scientific advancements and improved patient care.

Awards and Honors

Dr. Marjan Ghaemi has received several awards and honors in recognition of her academic excellence and contributions to reproductive medicine. She achieved the highest national board exam score in OB/GYN in 2019, demonstrating her outstanding medical knowledge and expertise. Her research on polycystic ovary syndrome (PCOS) and infertility treatments has been acknowledged in various academic and clinical circles. She has also played a pivotal role in medical research and journal editing, earning recognition for her editorial leadership in Fertility, Gynecology and Andrology and Journal of Family and Reproductive Health. As a Clinical Research Manager at Farzan Clinical Research, she was part of a team that earned national recognition as a top knowledge-based institute. Additionally, her contributions to medical IT and e-learning have been praised, as she has led projects in digital health solutions for reproductive medicine. Her work in gynecological cancer quality-of-life studies has also been highlighted in medical research communities. With her achievements in academia, research, and digital innovation, Dr. Ghaemi continues to be recognized as a leading figure in reproductive health and infertility research, making significant contributions to the field.

Conclusion

Dr. Marjan Ghaemi is an exceptional researcher and clinician in reproductive medicine, with expertise spanning gynecology, infertility, and endocrinology. Her contributions to clinical research, medical education, and digital health innovation have positioned her as a leader in the field. With a strong academic background, she has conducted impactful research on PCOS, IVF, and gynecological health, improving fertility treatment outcomes. Her editorial roles in leading journals further emphasize her dedication to advancing scientific knowledge. She has also played a key role in integrating digital health solutions into reproductive medicine, enhancing patient education and research methodologies. While she has achieved significant milestones, expanding her international collaborations and high-impact publications could further elevate her global presence. Overall, her dedication to evidence-based medicine and patient-centered care makes her a strong candidate for prestigious research awards. Dr. Ghaemi’s work is instrumental in shaping the future of reproductive health, and she remains committed to pioneering advancements in infertility treatments and women’s healthcare. With her expertise, leadership, and passion for research, she continues to make remarkable contributions to medical science and patient well-being.

Publications Top Notes

  1. Title: Uterus transplantation: A bibliometric review of six-decade study from 1960 to 2024
    Authors: R. Akbari, M. Ghaemi, Z.Y. Panahi
    Year: 2025
    Citations: 1

  2. Title: The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis
    Authors: A.M. Tarafdari, F. Keikha, F. Asadi, M. Forouzin, M. Ghaemi
    Year: 2024

  3. Title: Knowledge, attitudes, and practices of healthcare providers among women oncofertility in Iran: a cross-sectional study
    Authors: M. Ghaemi, I. Rokhzadi, M. Dashtkoohi, N. Eshraghi, M. Fakehi
    Year: 2024

  4. Title: Potential efficacy of digital polymerase chain reaction for non-invasive prenatal screening of autosomal aneuploidies: a systematic review and meta-analysis
    Authors: M. Parsaei, M. Dashtkoohi, T. Salmani, M. Ghaemi, S. Hantoushzadeh
    Year: 2024

  5. Title: The association between increased fetal movements in the third trimester and perinatal outcomes; a systematic review and meta-analysis
    Authors: S. Hantoushzadeh, O. Kohandel Gargari, M. Jamali, Z. Panahi, G.R. Habibi
    Year: 2024

  6. Title: Breast Implant Illness as a Challenging Disorder in Clinics
    Authors: F.G. Vahdani, M. Ghaemi, M. Haddadi
    Year: 2024

  7. Title: The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: A cohort study
    Authors: M. Aryavand, M. Noorzadeh, M. Ghaemi, S.E. Delfan, V. Marsoosi
    Year: 2024

  8. Title: Analysis of medico-legal claims related to deliveries: Caesarean section vs. vaginal delivery
    Authors: N. Eshraghi, M. Ghaemi, Z. Shabannejad, Z. Mansouri, S. Hantoushzadeh
    Year: 2024
    Citations: 1

  9. Title: The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
    Authors: M. Ghaemi, N. Seighali, A. Shafiee, Z.Y. Panahi, S. Hantoushzadeh
    Year: 2024
    Citations: 1

 

 

Wei Zhang | Health Professions | Best Researcher Award

Prof. Dr. Wei Zhang | Health Professions | Best Researcher Award

Professor at School of Nursing, Jilin University, China

Dr. Zhang Wei is a distinguished professor at Jilin University’s School of Nursing, where she leads the Department of Obstetrics and Gynecology Nursing. Her extensive career encompasses significant contributions to maternal and child health nursing, mental health nursing, and nursing education. Dr. Zhang has published over 40 papers as the first or corresponding author, with more than 30 in SCI-indexed journals, underscoring her commitment to advancing nursing science.

Professional Profile

Education

Dr. Zhang’s academic journey began with a bachelor’s degree in Maternal and Child Health from Jilin University’s Norman Bethune College of Medicine in 2002. She then earned a master’s degree in Women’s Health from the same institution in 2005. Pursuing further specialization, she obtained her Ph.D. in Immunology from Jilin University’s First Hospital in 2012. Demonstrating a commitment to interdisciplinary research, Dr. Zhang completed a postdoctoral fellowship in Social Medicine and Health Management at Jilin University’s School of Public Health between 2015 and 2021.

Professional Experience

Dr. Zhang’s professional trajectory at Jilin University is marked by progressive academic appointments. She began as a teaching assistant in the School of Nursing in 2005, advanced to lecturer in 2008, and was promoted to associate professor in 2014. In September 2023, she achieved the rank of professor. Throughout her tenure, Dr. Zhang has been instrumental in curriculum development and has served on both the Academic and Teaching Committees of the School of Nursing.

Research Interests

Dr. Zhang’s research interests are diverse and impactful. She focuses on maternal and child health nursing, emphasizing health promotion and care for women during critical life stages such as pregnancy, perimenopause, and adolescence. Her work in mental health nursing addresses psychological well-being, while her studies in chronic disease management concentrate on nursing care and preventive measures for female reproductive system cancers, including breast and gynecological tumors. Additionally, Dr. Zhang is dedicated to nursing education, exploring innovative teaching models and methods, particularly in blended learning environments.

Research Skills

Dr. Zhang possesses a robust set of research skills, including proficiency in systematic reviews and meta-analyses, as evidenced by her publications on topics like the effectiveness of family-centered interventions for caregivers and internet-based cognitive behavioral therapy for cancer patients. She is adept at both qualitative and quantitative research methodologies, enabling her to conduct comprehensive studies that inform evidence-based nursing practices.

Awards and Honors

Throughout her career, Dr. Zhang has received numerous accolades recognizing her contributions to nursing education and research. Notably, she was awarded the third prize in the 17th Jilin Province Higher Education Scientific Research Achievement Awards in November 2022 for her work on blended teaching models in obstetrics and gynecology nursing. She also received the Excellence Award for Undergraduate “Classroom Teaching Quality” at Jilin University for the 2021-2022 academic year, reflecting her dedication to teaching excellence.

Conclusion

Dr. Zhang Wei’s exemplary career in nursing is characterized by her unwavering commitment to advancing healthcare through research, education, and leadership. Her multidisciplinary expertise and dedication to improving women’s health have significantly impacted both the academic community and clinical practice. Dr. Zhang continues to inspire future generations of nurses and healthcare professionals through her innovative work and steadfast dedication to the field.

Publication Top Notes

  1. “Effectiveness of Meaning-Centered Interventions on Existential Distress and Mental Health Outcomes in Cancer Survivors and Their Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Dongsheng Xu, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2025
    • Journal: Worldviews on Evidence-Based Nursing
  2. “Effects of Nurse-Led e-Health Interventions on the Health-Related Outcomes of Pregnant Women: A Systematic Review”
    • Authors: Yujie Han, Qi Tian, Mengmeng Xu, Ziqi Wang, Wei Zhang
    • Year: 2025
    • Journal: Journal of Clinical Nursing
  3. “The Impact of Simulation-Based Learning on Nursing Decision-Making Ability: A Meta-Analysis”
    • Authors: Wei Zhao, Mengmeng Xu, Qi Tian, Ziqi Wang, Wei Zhang
    • Year: 2024
    • Journal: Clinical Simulation in Nursing
  4. “Effectiveness of Family-Centered Interventions for Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2024
    • Journal: Journal of Clinical Nursing
    • Citations: 2

 

Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Dr. Chaima Jemai | Medicine and Dentistry | Best Researcher Award

Dr. Chaima Jemai | Medicine and Dentistry | Best Researcher Award

Doctorate at National Institute of Nutrition of Tunis (Department C), Tunisia.

Dr. Jemai Chaima is a distinguished researcher with a Doctorate in Medicine awarded with the highest honors in October 2019. Her academic journey includes supplementary certifications in diabetic foot management and thyroidology, showcasing her commitment to specialized medical research. She has excelled in her field by successfully completing the final specialty competition in Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020. Dr. Chaima’s research focuses on critical areas within nutrition, reflecting her expertise and dedication to advancing healthcare. Her qualifications and achievements highlight her significant contributions to medical research and clinical practice. With a deep understanding of the impact of nutrition on health, Dr. Chaima stands out as a leading figure in her field, making her an ideal candidate for the Research for Excellence in Research award. Her work promises to enhance patient outcomes and drive advancements in medical science.

Profile

Education🎓

Dr. Jemai Chaima’s educational background reflects a strong commitment to advancing her expertise in medicine. She earned her Doctorate d’État in Medicine on October 24, 2019, with the distinction of “très honorable avec félicitations du jury,” highlighting her exceptional research and academic performance. In addition to her doctoral degree, Dr. Chaima pursued supplementary certificates to further enhance her specialization. She completed a Certificate in Diabetic Foot Management from the Faculty of Medicine of Sousse in 2018/2019 and another in Thyroidology from the Faculty of Medicine of Tunis in 2021. These advanced studies underscore her dedication to expanding her knowledge in critical areas of medicine. Furthermore, Dr. Chaima excelled in the final specialty competition for Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020, showcasing her advanced skills and readiness to contribute significantly to her field.

Professional Experience 🏢

Dr. Jemai Chaima brings a wealth of expertise in the field of medicine, with a specialized focus on Nutrition and Nutritional Diseases. Since earning her Doctorate in Medicine in October 2019, she has demonstrated remarkable dedication to her field. Her professional journey includes the completion of significant supplementary certificates, such as diabetic foot management and thyroidology, which highlight her commitment to advancing her knowledge and skills. In September 2020, she excelled in the final specialty competition, further solidifying her specialization in Nutrition and Nutritional Diseases. The following month, she succeeded in the Hospital-University Assistant competition, reflecting her readiness to contribute to both clinical practice and academic research. Dr. Chaima’s extensive training and competitive achievements position her as a leading expert, dedicated to addressing critical health issues through her research and clinical practice.

Environmental Health

Dr. Jemai Chaima’s contributions to environmental health are deeply integrated with her expertise in Nutrition and Nutritional Diseases. Her research explores the intersection of diet and environmental factors, focusing on how nutritional choices and environmental conditions impact overall health. By examining the effects of environmental pollutants and dietary habits on chronic diseases, Dr. Chaima provides valuable insights into how these factors contribute to public health issues. Her work is particularly relevant in understanding how environmental conditions exacerbate nutritional deficiencies and contribute to various health conditions. Through her specialized research and clinical practice, she aims to develop strategies to mitigate these impacts, ultimately improving community health outcomes. Dr. Chaima’s commitment to addressing environmental health issues highlights her dedication to enhancing both individual and public health through a comprehensive approach that combines environmental and nutritional science.

Research Interests 🔬

Dr. Jemai Chaima’s research interests are centered on the intersection of nutrition and medical sciences, particularly focusing on the management and prevention of nutrition-related diseases. Her expertise encompasses diabetic foot management, where she explores innovative approaches to treat and prevent complications associated with diabetes. Additionally, she has a strong interest in thyroidology, investigating the impact of thyroid disorders on nutritional health and overall well-being. Dr. Chaima’s work aims to integrate advanced nutritional strategies into clinical practice to enhance patient outcomes and address prevalent health issues. Her research is driven by a commitment to advancing knowledge in the field of nutrition and its role in managing chronic diseases, ultimately contributing to improved healthcare solutions and patient care. Through her specialized studies, Dr. Chaima seeks to bridge gaps between nutritional science and clinical application, fostering advancements that benefit both individual patients and the broader medical community.

Award and Honors

Dr. Jemai Chaima has garnered notable recognition and honors throughout her distinguished medical career. She earned her Doctorate in Medicine with the highest distinction (“très honorable avec félicitations du jury”) in October 2019, reflecting her outstanding research and academic excellence. Her commitment to advancing her expertise is further demonstrated by her completion of supplementary certificates in diabetic foot management and thyroidology from respected medical faculties in Tunisia. Additionally, Dr. Chaima achieved significant milestones in her specialty with successful completion of the final specialty competition in Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020. These accolades underscore her exceptional proficiency and dedication to her field, highlighting her significant contributions to medical research and practice. Her recognition reflects her ongoing commitment to excellence and her impactful role in advancing medical knowledge and patient care.

Research Skills

Dr. Jemai Chaima possesses a robust set of research skills that underscore her expertise in the field of Medicine, particularly in Nutrition and Nutritional Diseases. Her doctoral research, which earned her the highest distinction, reflects her advanced proficiency in designing and conducting complex studies. Dr. Chaima’s skills include a deep understanding of clinical research methodologies, data analysis, and evidence-based practice, essential for addressing intricate health issues related to nutrition. Her additional qualifications in diabetic foot management and thyroidology further enhance her research capabilities, providing her with a comprehensive perspective on various medical conditions. She is adept at integrating scientific knowledge with practical applications, which is crucial for developing effective interventions and treatments. Dr. Chaima’s ability to apply her research skills to real-world problems exemplifies her commitment to advancing medical science and improving patient care.

Conclusion

Jemai Chaima’s exceptional academic credentials, specialized research, and dedication to her field make her a strong candidate for the Research for Excellence in Research award. Her advanced qualifications, successful competitions, and specialized expertise in Nutrition and Nutritional Diseases underscore her significant contributions to medical research and practice. Dr. Chaima’s work exemplifies the high standards of research excellence and holds promise for continued impact in improving healthcare outcomes.

Publications Top Notes 📚
  1. Childhood obesity in Tunisia: prevalence and risk factors | Obésité chez l’enfant tunisien d’âge préscolaire: prévalence et facteurs de risque
    • Authors: M. Naifar, Y. Htira, C. Jemai, Z. H. Ali, F. B. Mami
    • Year: 2023
  2. Audit of glycemic control of diabetic patients on insulin analogues: About 2915 insured persons of the CNAM (Tunisia) | Audit de l’équilibre glycémique de patients diabétiques sous analogues de l’insuline: à propos de 2915 assurés de la CNAM (Tunisie)
    • Authors: S. Dogui, Y. Htira, C. Jemai, W. Echater, F. B. Mami
    • Year: 2022
  3. Prevalence of Cardiovascular Risk Factors in Type 1 Diabetes Mellitus Patients
    • Authors: S. Bougatf, Z. H. Ali, Y. Htira, I. Hedfi, F. B. Mami
    • Year: 2022

 

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11

Cameron Prior | Internal Medicine | Best Researcher Award

Dr. Cameron Prior | Internal Medicine | Best Researcher Award

Medicine Resident at Willows Veterinary Referral Centre, United Kingdom.

Dr. Najib George Awad is a renowned theologian and scholar with a rich academic background and extensive research experience. He holds dual doctoral degrees, including a Doctor Theol. Habil. in Historical/Arabic-Oriental Theology from Philipps Universität, Marburg, Germany, and a Doctor Phil. in Systematic Theology from King’s College, University of London. With a diverse teaching and academic career spanning prestigious institutions such as Rheinische Friedrich Wilhelm Universität Bonn in Germany and Hartford Seminary in Connecticut, Dr. Awad has made significant contributions to the field of theology. He is widely recognized for his groundbreaking research on topics ranging from Christian and Muslim Kalām to the theology of the Reformation. Dr. Awad’s publications include numerous monographs and articles that explore theological discourse across cultures and religions. His work reflects a deep commitment to fostering dialogue and understanding in a complex and diverse global landscape.

Professional Profiles:

Education

Dr. Cameron Prior completed his Bachelor of Veterinary Science (BVSc) degree at the University of Pretoria, Onderstepoort, South Africa, graduating in the top 10 of his class in 2017. Following this, he pursued further education and earned a Master of Science (MSc) degree in Small Animal Internal Medicine from the University of Pretoria, Onderstepoort, South Africa, in June 2020. His thesis and subsequent publication focused on the Prevalence of methicillin-resistant Staphylococcus pseudintermedius in dogs with skin and ear infections in South Africa.

Professional Experience

Dr. Cameron Prior brings a wealth of experience to the field of veterinary medicine. Currently serving as an Internal Medicine Resident at Willows Veterinary Centre and Referral Service, he is actively pursuing credentials for the European Diploma in Small Animal Internal Medicine (Dip ECVIM-CA). Dr. Prior’s interests span antimicrobial stewardship, gastroenterology, diabetes, and aspergillosis, and he has spearheaded the establishment of a diabetic clinic at Willows Veterinary Centre. His dedication to advancing veterinary medicine is evident through his involvement in multiple clinical research projects. Prior to his current role, he completed a rotating small animal internship at Veterinary Specialist Scotland and served as a small animal veterinarian at Boskruin Veterinary Clinic and Onderstepoort Veterinary Academic Hospital in South Africa. In addition to his clinical work, Dr. Prior has contributed to the development of antibiotic guidelines, co-authored a textbook, and engaged in academic pursuits such as lecturing and pursuing advanced certifications.

Research Interest

Dr. Cameron Prior’s research interests encompass several areas within veterinary medicine. He is particularly passionate about antimicrobial stewardship, aiming to optimize the use of antimicrobials to combat resistance and promote patient safety. Additionally, Dr. Prior is deeply involved in studies related to endocrinopathy, focusing on disorders of the endocrine system in small animals and exploring innovative approaches to diagnosis and treatment. Furthermore, he is dedicated to facilitating multiple research projects aimed at enhancing the evidence base of veterinary medicine, with a keen interest in gastroenterology and fungal infections such as aspergillosis. Dr. Prior actively seeks collaborative opportunities with colleagues across Europe to advance clinical research and improve patient care in veterinary practice.

Award and Honors

Dr. Cameron Prior has received recognition for his contributions to veterinary medicine, including awards and honors for his exemplary work and dedication to advancing the field. Some of these awards may include commendations for his research achievements, clinical excellence, and contributions to antimicrobial stewardship and endocrinology in small animal medicine. Additionally, he may have received accolades for his leadership roles, such as serving as Chairman of the South African Dermatology Interest Group and his involvement in drafting guidelines for organizations like the European Network for the Optimization of Antimicrobial Therapy (ENOVAT). These honors reflect Dr. Prior’s commitment to excellence and innovation in veterinary practice.

Research Skills

Dr. Cameron Prior possesses a diverse set of research skills that contribute to his success in veterinary medicine. His expertise encompasses various areas, including antimicrobial stewardship, endocrinopathy, and clinical research in small animal internal medicine. Dr. Prior is proficient in designing and conducting clinical research projects, as evidenced by his involvement in multiple studies aimed at enhancing the evidence base of veterinary medicine. He demonstrates strong analytical abilities in data analysis and interpretation, allowing him to draw meaningful conclusions from research findings. Additionally, Dr. Prior is skilled in literature review and critical appraisal, enabling him to stay abreast of current developments in veterinary science. His research skills are complemented by effective communication and collaboration abilities, which facilitate partnerships with colleagues across Europe and the dissemination of research findings through publications and presentations.

Publications

  1. Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011–2021)
    • Journal: Journal of Small Animal Practice
    • Year: 2024
    • DOI: 10.1111/jsap.13736
  2. Efficacy of antimicrobial and nutraceutical treatment for canine acute diarrhoea: A systematic review and meta-analysis for European Network for Optimization of Antimicrobial Therapy (ENOVAT) guidelines
    • Journal: The Veterinary Journal
    • Year: 2024
    • DOI: 10.1016/j.tvjl.2023.106054
    • Source: Cameron Prior
  3. Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020–2022)
    • Journal: Journal of Feline Medicine and Surgery
    • Year: 2023
    • DOI: 10.1177/1098612×231194460
    • Source: Cameron Prior
  4. Prevalence of methicillin resistance in Staphylococcus pseudintermedius isolates from dogs with skin and ear infections in South Africa
    • Journal: Journal of the South African Veterinary Association
    • Year: 2022
    • DOI: 10.36303/JSAVA.2022.93.1.505
  5. Overview and Evaluation of Existing Guidelines for Rational Antimicrobial Use in Small-Animal Veterinary Practice in Europe
    • Journal: Antibiotics
    • Year: 2021
    • DOI: 10.3390/antibiotics10040409
    • Source: Multidisciplinary Digital Publishing Institute

 

 

Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Dr. Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Oncology consultant/Researcher of INT IRCCS Fondazione G. Pascale, Italy.

Claudia Von Arx is a dedicated researcher and medical professional with a wealth of experience in oncology research. She completed her medical degree at the University of Naples “Federico II” and subsequently specialized in Medical Oncology. Claudia pursued her passion for research by undertaking a PhD at Imperial College London, focusing on the development of recombinant OPCML tumor suppressor protein as a therapy for ovarian cancer. With extensive experience as a clinical research fellow at prestigious institutions like Imperial College London and INT IRCSS Fondazione G. Pascale of Naples, Claudia has contributed significantly to preclinical and translational research in oncology. Her expertise lies in developing predictive biomarkers, planning and conducting clinical trials, and exploring innovative treatment strategies for various types of cancer. Claudia’s commitment to advancing cancer research and patient care underscores her dedication to improving outcomes in oncology.

Professional Profiles:

Education

Ali Gholizadeh pursued his academic journey with distinction, attaining a Master of Science (2) in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers (ENSAM) in 2020. Prior to this, he completed a Master of Science (1) in Mechanical Engineering, with a focus on Fluid Dynamics, also from ENSAM, in 2018. Ali’s educational foundation was laid with a Bachelor of Science in Mechanical Engineering from Shahid Bahonar University of Kerman in 2017. Throughout his academic career, Ali demonstrated exceptional aptitude and dedication, evidenced by his research projects and academic achievements.

Professional Experience

Ali Gholizadeh is an accomplished engineer with a diverse background in research and development. Currently serving as a Research Engineer at the University of Liège, he specializes in the development of innovative chip architectures for biochemical workflows. With previous roles at Fluigent and the Science and Technology Research Center, Ali has honed his skills in microfluidic technologies, CAD design, and data analysis. His academic journey includes a Master’s degree in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers and a Bachelor’s degree in Mechanical Engineering from Shahid Bahonar University of Kerman. Throughout his career, Ali has demonstrated a strong commitment to advancing engineering solutions through cutting-edge research and development initiatives.

Research Interest

Ali Gholizadeh’s research interests encompass several areas of engineering, with a primary focus on microfluidic technologies and their applications. He is particularly interested in the design and optimization of microfluidic chips for various biochemical workflows, including sample preparation, analysis, and diagnostics. Additionally, Ali is passionate about exploring novel materials and fabrication techniques to enhance the performance and functionality of microfluidic devices. His research also extends to areas such as lab-on-a-chip systems, high-speed imaging, and instrument interface development. Overall, Ali’s goal is to contribute to the advancement of interdisciplinary research at the intersection of engineering, biology, and medicine, with the ultimate aim of addressing real-world challenges and improving human health.

Award and Honors

Ali Gholizadeh has received several honors and awards in recognition of his contributions to research and academia. Notably, he was selected as a ranked student for participation in a prestigious dual degree program between IUST and ENSAM, where his master’s project received the highest score by the jury. Additionally, he achieved the top 1% rank among 35,000 participants in the nationwide university entrance exam for graduate studies in Mechanical Engineering, earning a full scholarship to study at IUST. These accomplishments highlight Ali’s academic excellence and dedication to his field, positioning him as a promising young researcher in the engineering community.

Research Skills

Ali Gholizadeh possesses a diverse set of research skills that enable him to excel in his field. His expertise includes design and microfabrication of electromechanical instruments and microfluidic chips, along with proficiency in CAD, 3D printing, and software programming for development purposes. He is skilled in data analysis and post-processing, utilizing tools such as MATLAB, Python, and image processing techniques. Additionally, Ali has experience in high-speed imaging and microscopy, contributing to his ability to conduct detailed analysis and observation in his research projects. His critical thinking, problem-solving abilities, and strong teamwork skills further enhance his research capabilities, allowing him to make significant contributions to the advancement of engineering and technology.

Publications

  1. A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
    • Authors: C. von Arx, G. Della Vittoria Scarpati, L. Cannella, A. Ottaiano, S. Tafuto
    • Journal: ESMO Open
    • Year: 2024
    • Volume: 9
    • Issue: 5
    • Citations: 0
  2. Cancer genetic counselling for hereditary breast cancer in the era of precision oncology
    • Authors: M. Pensabene, A. Calabrese, C. von Arx, R. Caputo, M. De Laurentiis
    • Journal: Cancer Treatment Reviews
    • Year: 2024
    • Volume: 125
    • Citations: 0
  3. Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
    • Authors: R. Caputo, G. Buono, V.D. Lauro, F. Nuzzo, M. De Laurentiis
    • Journal: Future Oncology
    • Year: 2023
    • Volume: 19
    • Issue: 24
    • Pages: 1695–1708
    • Citations: 0
  4. The Complex Management of the Breast Angiosarcoma: A Retrospective Study
    • Authors: L. Cannella, F. Perri, O. Clemente, A. De Chiara, S. Tafuto
    • Journal: Oncology (Switzerland)
    • Year: 2023
    • Volume: 101
    • Issue: 4
    • Pages: 234–239
    • Citations: 1
  5. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
    • Authors: C. von Arx, P. De Placido, A. Caltavituro, M. Giuliano, L. Del Mastro
    • Journal: Cancer Treatment Reviews
    • Year: 2023
    • Volume: 113
    • Citations: 17
  6. Male Breast Cancer: From Molecular Genetics to Clinical Management
    • Authors: M. Pensabene, C. Von Arx, M. De Laurentiis
    • Journal: Cancers
    • Year: 2022
    • Volume: 14
    • Issue: 8
    • Pages: 2006
    • Citations: 10
  7. Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
    • Authors: A. Ottaiano, M. Berretta, C. Von Arx, M. Capozzi, M. Caraglia
    • Journal: Frontiers in Oncology
    • Year: 2022
    • Volume: 12
    • Pages: 852445
    • Citations: 1
  8. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
    • Authors: I.M. Modlin, M. Kidd, K. Oberg, I.A. Drozdov, A. Kitz
    • Journal: Annals of Surgical Oncology
    • Year: 2021
    • Volume: 28
    • Issue: 12
    • Pages: 7506–7517
    • Citations: 24
  9. Selinexor and the selective inhibition of nuclear export: A new perspective on the treatment of sarcomas and other solid and non-solid tumors
    • Authors: A.L. Marretta, G. Di Lorenzo, D. Ribera, A. Pizzolorusso, S. Tafuto
    • Journal: Pharmaceutics
    • Year: 2021
    • Volume: 13
    • Issue: 9
    • Pages: 1522
    • Citations: 2
  10. Uptake of trastuzumab biosimilars for the treatment of HER2-positive breast cancer: A real-world experience from a cancer center
    • Authors: M. Piezzo, R. D’aniello, I. Avallone, M. De Laurentiis, P. Maiolino
    • Journal: Pharmaceutics
    • Year: 2021
    • Volume: 13
    • Issue: 5
    • Pages: 684
    • Citations: 3